Abstract:Differential diagnosis of Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) and B cell lymphoma, unclassifiable, with features intermediate between BL and DLBCL (intermediate BL/DLBCL) can be difficult. We studied 97 Chinese pediatric mature aggressive B-cell lymphomas including 81 BL cases, eight DLBCL cases and eight intermediate BL/DLBCL cases using immunohistochemistry, interphase fluorescence in situ hybridization (FISH) and Epstein-Barr virus (EBV) in situ hybridization. Our results showed that there were no significant differences in the expression of CD10 and BCL6 among cases of BL (91% and 86%, respectively), DLBCL (75% and 63%, respectively) and intermediate BL/DLBCL (75% and 63%, respectively) (p > 0.05). The expression of BCL2 (3% in BL, 50% in DLBCL, 50% in intermediate BL/DLBCL), expression of MUM1 (17% in BL, 63% in DLBCL, 63% in intermediate BL/DLBCL) and mean Ki-67 proliferation index (PI) (93% in BL, 83% in DLBCL, 80% in intermediate BL/DLBCL) were significantly different between BL and DLBCL and between BL and intermediate BL/DLBCL. The frequency of an extra copy of BCL6 (0% in BL, 37.5% in DLBCL, 25% in intermediate BL/DLBCL) and EBV-encoded RNA (EBER) positivity (48% in BL, 0% in DLBCL and intermediate BL/DLBCL) were also significantly different between BL and DLBCL and between BL and intermediate BL/DLBCL. The frequency of C-MYC rearrangement in BL (98%) was much higher than in DLBCL (37.5%) and intermediate BL/DLBCL (50%). Our findings suggest that diagnosis of the mature aggressive B-cell lymphomas in pediatrics should be based on the comprehensive review and integration of morphological, immunohistochemical and molecular genetic features. The expression of CD10 and BCL6 but not BCL2, a high Ki-67 PI (>90%) and a C-MYC rearrangement but not BCL2 or BCL6 rearrangement are the features of BL. MUM1 is not an exclusionary diagnostic marker for BL. As the immunophenotype and molecular genetic features of DLBCL and intermediate BL/DLBCL are similar, intermediate BL/DLBCL is more likely a subgroup of DLBCL in the pediatric population. Regardless of the expression of CD10 and BCL6, strong staining for BCL2, Ki-67 PI below 90% and the presence of extra copies of BCL6 favor a diagnosis of DLBCL or intermediate BL/DLBCL.

Sporadic Burkitt Lymphoma in Southern China: 12 Years' Experience in a Single Institution in Guangzhou.

Oculomotor Nerve Palsy As A Preceding Symptom of Adult Sporadic Burkitt Lymphoma: A Case Report and Review of the Literature

[Clinical Analysis of 41 Patients with Burkitt's Lymphoma].

Clinical and Pathological Features of the Sporadic Burkitt's Lymphoma

Clinicopathological Analysis of Sporadic Burkitt's and Burkitt-like Lymphoma

Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China

Pediatric Sporadic Burkitt Lymphoma of the Head and Neck: A Case Series and Analysis of National Trends

Clinical Study of 40 Children with Burkitt's and Burkitt-like Lymphoma

Clinical and pathologic features of jaw Burkitt's lymphoma in children

Clinicopathologic Study of 105 Lymphoblastic Lymphoma Cases

Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study

Morphological, Immunophenotypic And Molecular Characterization Of Mature Aggressive B-Cell Lymphomas In Chinese Pediatric Patients

Clinical Analysis of 13 Cases with Burkitt Lymphoma or Burkitt-like Lymphoma

Primary gastric Burkitt's lymphoma: a clinicopathological analysis of four cases

A Prospective Study of 728 Cases of Non-Hodgkin Lymphoma from a Single Laboratory in Shanghai, China

Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China

Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behaviour.

Identification of Clinical Molecular Targets for Childhood Burkitt Lymphoma.

Analysis of Clinical Characteristics of 516 Patients with Non-Hodgkin's Lymphoma in Shanghai Area.

Burkitt lymphoma manifested by initial oral and maxillofacial lesions: a case report in a child patient and review of related articles